ILD, Fatigue & Safety: Managing T-DXd in Clinical Practice

Interstitial lung disease remains the most feared toxicity of T-DXd — but early detection and education make a difference.

Drs. Pegram and Yan discuss why education and early intervention are the keys to managing the full safety profile including challenges like fatigue. Inside is a candid look at the strategies helping clinicians deliver this “game-changer” therapy safely and effectively.